Global Cosmetic Compliance
Intelligence & Solutions
Home / News / Details

EU SCCS Concludes Hydroxyapatite (nano) Is Safe at Higher Levels for Oral Use

In April 2025, EU Scientific Committee on Consumer Safety (SCCS) published a preliminary opinion on hydroxyapatite (CAS No. 1306-06-5) in nano form, following the industry's fourth submission of a safety assessment dossier for the ingredient. After reviewing public comments received, SCCS issued its final opinion on July 1, 2025.1

Please Log in or Sign up (FREE) to read the full content.
Tags : IngredientsEU
We provide full-scale global cosmetic market entry services (including cosmetic registering & filing, regulatory consultation, customized training, market research, branding strategy). Please contact us to discuss how we can help you by [email protected]
Copyright: unless otherwise stated all contents of this website are ©2026 - REACH24H Consulting Group - All Rights Reserved - For permission to use any content on this site, please contact [email protected]
User Guide